AGC Biologics Honored by Customers and Industry Leaders for Excellence in Contract Development and Manufacturing

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Health
Genetics
Clinical Trials
Research
Science
Pharmaceutical
Biotechnology
CDMO Leadership awards

More Like This

Business Wire logo

AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

PR Newswire associated0

Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence

PR Newswire associated0

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

GlobeNewswire associated0

Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma

PR Newswire associated0

BioCina and NovaCina Merger Bolsters Global CDMO Industry

Curia Receives 2024 CDMO Leadership Award

Going Global - Chime Biologics Embraces Innovation and Quality with Partners

Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital